Arkolith/Insider Trading/VYNE/Form 4

Lepore Patrick G

DirectorVYNE Therapeutics Inc. (VYNE) · full profile →Form 4 · filed Jan 16, 2025
Net Buying
Open-Market Buys
$44K
Open-Market Sells
$0
Net Open-Market Flow
$44K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 15, 2025Buy(P)15K$2.92$44K51K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001415889-25-001574) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML